Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of TCERG1 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of TCERG1 mRNA | affects expression | 21346803
|
D004391 |
Dust |
Dust results in decreased expression of TCERG1 mRNA | decreases expression | 17805423
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of TCERG1 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of TCERG1 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TCERG1 mRNA | affects cotreatment|increases expression | 17942748
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of TCERG1 mRNA | affects cotreatment|increases expression | 17183730
|
D012643 |
Selenium |
[Selenium co-treated with Vitamin E] results in decreased expression of TCERG1 mRNA | affects cotreatment|decreases expression | 19244175
|
D012643 |
Selenium |
Selenium results in decreased expression of TCERG1 mRNA | decreases expression | 19244175
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TCERG1 mRNA | affects cotreatment|increases expression | 17942748
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of TCERG1 mRNA | affects cotreatment|increases expression | 17183730
|
D014810 |
Vitamin E |
[Selenium co-treated with Vitamin E] results in decreased expression of TCERG1 mRNA | affects cotreatment|decreases expression | 19244175
|
D014810 |
Vitamin E |
Vitamin E results in decreased expression of TCERG1 mRNA | decreases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.28 | 11752688 14514962 15322242 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
9.28 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.13 | 19490988 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.26 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.85 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.66 | 16835633 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.55 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.14 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.74 | 17497229 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.72 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.78 | 15885639 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 17157402 18396377 17688650 19460635 16609825 18558336 18775368 18985861 20603192 19232924 18940202 18316065 18177632 15238991 17507914 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.17 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.25 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.11 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.43 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.43 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.69 | 20435547 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
4.19 | 16050911 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.96 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
3.04 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
3.04 | 16705839 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.47 | 16120746 18850075 18670907 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
2.90 | 6135515 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.77 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.34 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
3.02 | 16919318 15861022 11677210 17110522 16105132 17333356 17681005 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.18 | 12621046 15340226 15668235 8697196 16354765 |
MESH:D003092 |
Colitis |
|
Selenium |
4.04 | 17936198 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.24 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.88 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.88 | 16575769 17688650 8888407 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
3.88 | 19769572 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
11.77 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
11.77 | 18551238 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
12.60 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
12.60 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
12.60 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
12.60 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
12.60 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.91 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.27 | 1851702 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
5.02 | 9068938 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.58 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.22 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.42 | 12538720 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.21 | 9294722 10568697 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.41 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.23 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.03 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.77 | 7562514 6426943 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.56 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.35 | 3659116 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
8.43 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
8.43 | 14986274 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.71 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.20 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.37 | 18558336 8888407 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.21 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.91 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.90 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
6.90 | 16080930 |
MESH:D006333 |
Heart Failure |
|
Selenium |
3.19 | 17162251 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.54 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.15 | 15340226 16120746 12621046 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.76 | 16863852 16490937 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
4.29 | 14716179 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.15 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.36 | 18606429 8697196 15340226 16354765 16959395 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.97 | 18850075 18670907 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.88 | 16612254 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.07 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.68 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.62 | 17937319 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.95 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
12.04 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
12.04 | 16624496 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.54 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
2.91 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
4.09 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
7.94 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.94 | 16705839 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.18 | 17596541 16294345 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.39 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
2.39 | 16169303 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
4.59 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.59 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
6.14 | 2876786 6135515 2876784 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.14 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
3.31 | 16863852 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.58 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.35 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
2.35 | 11062179 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
2.88 | 15318939 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.86 | 15107826 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.33 | 18765137 18803445 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.23 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.26 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.18 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
11.32 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
11.32 | 18551238 7678174 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.45 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.25 | 8888407 16359493 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
9.54 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
9.54 | 16049721 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.91 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.57 | 12520081 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
5.21 | 15087411 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.80 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
10.43 | 11896295 11118676 11222880 11399792 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
10.43 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
3.27 | 15084515 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.60 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.86 | 11422049 12752131 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.08 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.40 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.09 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
10.62 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
10.62 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
10.62 | 14763951 11738929 16876388 1511512 3137016 11044598 15475178 17978042 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.48 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.13 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.26 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.94 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.86 | 12833885 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.68 | 16517955 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.84 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.33 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.22 | 12697716 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.55 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.81 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.24 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.24 | 16049721 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.90 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
12.96 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
12.96 | 10091137 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.54 | 14692618 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.91 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.75 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.57 | 15886252 |